Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Registered dietitian Suzanne Fisher offers explains why nutrition is important to support metastatic breast cancer. She ...

Wendy Yeh, M.D. Chief Medical Officer, NGM Bio Dr. Yeh will oversee the continued clinical development of NGM Bio’s key ...

Two new composition of matter patents granted in the US and Europe Patents provide protection relating to lead compound S-pindolol benzoate ...

Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...

PH284 nasal spray increased hunger in cancer cachexia patients, showing a 71% improvement in subjective hunger scores compared to baseline. The phase 2A study demonstrated PH284's safety, with no ...

Reports Q3 revenue $234,000, consensus $179.25k. “We had a very productive quarter, with both PALISADE-3 and PALISADE-4 advancing towards ...

The tragedy of cancer is profound, but it feels even more devastating when it affects children, cutting into lives just ...

Biotech startup Tensegrity Pharma announced on the 31st raising 150 million yen in seed funding. This round saw participation from Mitsubishi UFJ Capital, bringing their cumulative seed round ...